1. Home
  2. CVKD vs GLXG Comparison

CVKD vs GLXG Comparison

Compare CVKD & GLXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • GLXG
  • Stock Information
  • Founded
  • CVKD 2022
  • GLXG 2013
  • Country
  • CVKD United States
  • GLXG Hong Kong
  • Employees
  • CVKD N/A
  • GLXG N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • GLXG
  • Sector
  • CVKD Health Care
  • GLXG
  • Exchange
  • CVKD Nasdaq
  • GLXG NYSE
  • Market Cap
  • CVKD 20.8M
  • GLXG 17.7M
  • IPO Year
  • CVKD 2023
  • GLXG 2024
  • Fundamental
  • Price
  • CVKD $19.72
  • GLXG $0.98
  • Analyst Decision
  • CVKD Strong Buy
  • GLXG
  • Analyst Count
  • CVKD 1
  • GLXG 0
  • Target Price
  • CVKD $32.00
  • GLXG N/A
  • AVG Volume (30 Days)
  • CVKD 51.3K
  • GLXG 3.3M
  • Earning Date
  • CVKD 03-10-2025
  • GLXG 02-16-2025
  • Dividend Yield
  • CVKD N/A
  • GLXG N/A
  • EPS Growth
  • CVKD N/A
  • GLXG N/A
  • EPS
  • CVKD N/A
  • GLXG 0.04
  • Revenue
  • CVKD N/A
  • GLXG $3,858,088.00
  • Revenue This Year
  • CVKD N/A
  • GLXG N/A
  • Revenue Next Year
  • CVKD N/A
  • GLXG N/A
  • P/E Ratio
  • CVKD N/A
  • GLXG $22.24
  • Revenue Growth
  • CVKD N/A
  • GLXG N/A
  • 52 Week Low
  • CVKD $5.40
  • GLXG $0.70
  • 52 Week High
  • CVKD $21.30
  • GLXG $16.93
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 59.55
  • GLXG N/A
  • Support Level
  • CVKD $19.07
  • GLXG N/A
  • Resistance Level
  • CVKD $19.56
  • GLXG N/A
  • Average True Range (ATR)
  • CVKD 1.48
  • GLXG 0.00
  • MACD
  • CVKD 0.01
  • GLXG 0.00
  • Stochastic Oscillator
  • CVKD 69.69
  • GLXG 0.00

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About GLXG GALAXY PAYROLL GROUP LTD

Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.

Share on Social Networks: